Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	NASDAQ	Biotechnology	$97.06M	$9.01	-8.81%	$838.00k	450.50x	0.14
CPRX	CATALYST PHARMACEUTICALS INC	NASDAQ	Biotechnology	$706.10M	$6.87	-0.72%	$60.73M	15.61x	0.12
EXEL	EXELIXIS INC	NASDAQ	Biotechnology	$5.68B	$17.70	-0.28%	$401.79M	18.83x	0.16
HALO	HALOZYME THERAPEUTICS INC	NASDAQ	Biotechnology	$6.18B	$44.82	1.11%	$305.20M	14.55x	3.47
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$2.45B	$41.50	2.32%	$94.18M	50.00x	1.16
INCY	INCYTE CORP	NASDAQ	Biotechnology	$16.64B	$75.11	-2.34%	$634.33M	17.80x	0.31
SESN	SESEN BIO INC	NASDAQ	Biotechnology	$103.92M	$0.52	1.36%	$45.82M	2.00x	0.31
MRNA	MODERNA INC	NASDAQ	Biotechnology	$52.53B	$132.06	-4.04%	$16.55B	3.63x	0.62
CLNN	CLENE INC	NASDAQ	Biotechnology	$153.71M	$2.43	-10.99%	$18.51M	8.68x	25.46
CORT	CORCEPT THERAPEUTICS INC	NASDAQ	Biotechnology	$2.13B	$20.00	-0.25%	$134.73M	20.20x	0.15
CDMO	AVID BIOSERVICES INC	NASDAQ	Biotechnology	$764.40M	$12.38	2.23%	$21.33M	77.38x	4.55
XOMA	XOMA CORP	NASDAQ	Biotechnology	$197.13M	$17.26	-3.41%	$21.32M	15.98x	0.14
CRSP	CRISPR THERAPEUTICS AG	NASDAQ	Biotechnology	$4.06B	$52.38	-4.26%	$337.79M	12.65x	0.16
REGN	REGENERON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$75.36B	$686.02	0.60%	$9.48B	9.15x	0.32
GMAB	GENMAB A	NASDAQ	Biotechnology	$20.07B	$30.53	-0.97%	$582.54M	59.63x	0.10
VRTX	VERTEX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$68.67B	$268.48	0.05%	$3.06B	28.08x	0.31
UTHR	UNITED THERAPEUTICS CORP	NASDAQ	Biotechnology	$9.92B	$218.95	4.19%	$938.70M	14.35x	0.28
TECH	BIO-TECHNE CORP	NASDAQ	Biotechnology	$14.01B	$357.17	-2.01%	$352.93M	62.12x	0.34
BNTX	BIONTECH SE	NASDAQ	Biotechnology	$37.55B	$154.50	-5.34%	$19.99B	1.77x	0.28
AVIR	ATEA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$626.93M	$7.53	3.15%	$65.85M	12.98x	0.06
QURE	UNIQURE NV	NASDAQ	Biotechnology	$662.40M	$14.20	6.29%	$342.85M	2.01x	0.39
UPC	UNIVERSE PHARMACEUTICALS INC	NASDAQ	Biotechnology	$23.19M	$1.07	-2.20%	$14.23M	1.52x	0.19
LJPC	LA JOLLA PHARMACEUTICAL CO	NASDAQ	Biotechnology	$95.84M	$3.75	-1.83%	$17.40M	18.75x	-2.37
XNCR	XENCOR INC	NASDAQ	Biotechnology	$1.34B	$22.45	-1.32%	$116.74M	12.01x	0.12
PRTA	PROTHENA CORP PUBLIC LTD CO	NASDAQ	Biotechnology	$1.21B	$25.95	-1.82%	$72.78M	18.15x	0.33
NBIX	NEUROCRINE BIOSCIENCES INC	NASDAQ	Biotechnology	$8.09B	$84.60	-2.19%	$129.30M	111.32x	0.54
GNFT	GENFIT SA	NASDAQ	Biotechnology	$171.86M	$3.45	-5.74%	$86.24M	2.10x	1.37
CLSD	CLEARSIDE BIOMEDICAL INC	NASDAQ	Biotechnology	$78.20M	$1.30	-8.45%	$262.00k	130.00x	0.14
SIGA	SIGA TECHNOLOGIES INC	NASDAQ	Biotechnology	$662.52M	$9.15	-15.51%	$89.81M	9.84x	0.10
ACST	ACASTI PHARMA INC	NASDAQ	Biotechnology	$40.30M	$0.91	0.22%	-$8.30M	-3.03x	0.03
SELB	SELECTA BIOSCIENCES INC	NASDAQ	Biotechnology	$104.90M	$0.69	-7.74%	$49.03M	3.00x	1.61
CARA	CARA THERAPEUTICS INC	NASDAQ	Biotechnology	$443.20M	$8.27	-3.27%	-$91.31M	-4.62x	0.10
AUPH	AURINIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.60B	$11.31	-4.48%	-$164.54M	-8.84x	0.13
VNDA	VANDA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$543.43M	$9.62	-1.23%	$27.20M	29.15x	0.20
RGNX	REGENXBIO INC	NASDAQ	Biotechnology	$834.64M	$19.35	-1.07%	$150.55M	8.00x	0.49
LQDA	LIQUIDIA CORP	NASDAQ	Biotechnology	$216.84M	$3.37	-28.30%	-$35.04M	-4.21x	0.69
OPNT	OPIANT PHARMACEUTICALS INC	NASDAQ	Biotechnology	$66.64M	$13.10	-4.45%	-$3.68M	-11.80x	0.54
ATNM	ACTINIUM PHARMACEUTICALS INC	NYSEMKT	Biotechnology	$132.48M	$5.57	-5.91%	-$24.05M	-4.89x	0.08
LUMO	LUMOS PHARMA INC	NASDAQ	Biotechnology	$64.11M	$7.66	-3.04%	-$30.15M	-2.19x	0.14
EDIT	EDITAS MEDICINE INC	NASDAQ	Biotechnology	$685.72M	$9.99	-8.26%	-$183.52M	-3.66x	0.22
LPTX	LEAP THERAPEUTICS INC	NASDAQ	Biotechnology	$98.92M	$1.12	-1.75%	-$41.87M	-2.60x	0.08
VTGN	VISTAGEN THERAPEUTICS INC	NASDAQ	Biotechnology	$210.66M	$1.02	-1.92%	-$36.69M	-2.22x	0.13
ABCM	ABCAM PLC	NASDAQ	Biotechnology	$3.20B	$13.98	-6.05%	$2.60M	559.20x	0.50
HSTO	HISTOGEN INC	NASDAQ	Biotechnology	$8.94M	$0.18	-2.19%	-$11.24M	-0.66x	0.37
VIR	VIR BIOTECHNOLOGY INC	NASDAQ	Biotechnology	$3.02B	$22.82	-5.47%	$1.65B	2.45x	0.44
RPTX	REPARE THERAPEUTICS INC	NASDAQ	Biotechnology	$370.35M	$8.84	-5.15%	-$118.05M	-2.87x	0.30
AVEO	AVEO PHARMACEUTICALS INC	NASDAQ	Biotechnology	$137.91M	$4.00	-0.50%	-$36.73M	-3.36x	1.66
GANX	GAIN THERAPEUTICS INC	NASDAQ	Biotechnology	$30.42M	$2.56	-8.90%	-$14.69M	-2.08x	0.18
SEER	SEER INC	NASDAQ	Biotechnology	$444.59M	$7.12	-6.56%	-$73.86M	-5.61x	0.08
STTK	SHATTUCK LABS INC	NASDAQ	Biotechnology	$119.93M	$2.83	-5.03%	-$56.00M	-2.08x	0.09
FBIO	FORTRESS BIOTECH INC	NASDAQ	Biotechnology	$89.80M	$0.84	-6.17%	-$51.22M	-0.37x	2.19
ZLAB	ZAI LAB LTD	NASDAQ	Biotechnology	$3.33B	$34.05	-8.15%	-$540.09M	-5.76x	0.15
BMRN	BIOMARIN PHARMACEUTICAL INC	NASDAQ	Biotechnology	$14.57B	$78.78	-1.97%	$158.35M	375.14x	0.38
ADAG	ADAGENE INC	NASDAQ	Biotechnology	$123.17M	$2.82	0.00%	-$69.99M	-1.55x	0.21
BGNE	BEIGENE LTD	NASDAQ	Biotechnology	$12.70B	$122.99	-9.01%	-$1.87B	-79.35x	0.36
LOGC	LOGICBIO THERAPEUTICS INC	NASDAQ	Biotechnology	$13.71M	$0.42	-9.76%	-$33.67M	-0.37x	1.08
CDXS	CODEXIS INC	NASDAQ	Biotechnology	$643.24M	$9.85	-6.28%	-$13.32M	-29.85x	0.48
SLRX	SALARIUS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$9.93M	$0.18	-6.35%	-$17.01M	-0.48x	0.06
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	NASDAQ	Biotechnology	$9.51M	$1.00	-0.99%	-$5.74M	-0.28x	0.04
BYSI	BEYONDSPRING INC	NASDAQ	Biotechnology	$44.77M	$1.15	-8.00%	-$60.46M	-0.70x	2.07
IMMP	IMMUTEP LTD	NASDAQ	Biotechnology	$232.32M	$2.72	0.74%	-$19.07M	-11.93x	0.10
INMB	INMUNE BIO INC	NASDAQ	Biotechnology	$98.34M	$5.48	-24.62%	-$32.69M	-2.84x	0.25
ALBO	ALBIREO PHARMA INC	NASDAQ	Biotechnology	$408.36M	$20.86	-3.25%	-$19.53M	-12.27x	0.76
NVO	NOVO NORDISK A S	NYSE	Biotechnology	$249.43B	$107.98	0.13%	$9.92B	35.55x	1.96
SNDX	SYNDAX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$796.81M	$14.17	-2.68%	$17.87M	36.33x	0.13
EIGR	EIGER BIOPHARMACEUTICALS INC	NASDAQ	Biotechnology	$285.23M	$6.60	-2.37%	-$81.38M	-2.64x	0.58
EYEN	EYENOVIA INC	NASDAQ	Biotechnology	$72.51M	$2.16	0.47%	-$13.97M	-4.15x	0.35
NTRB	NUTRIBAND INC	NASDAQ	Biotechnology	$34.33M	$4.39	-3.94%	-$5.74M	-4.67x	0.07
NBRV	NABRIVA THERAPEUTICS PLC	NASDAQ	Biotechnology	$120.72M	$0.19	-2.55%	-$45.57M	-2.10x	0.47
MRUS	MERUS NV	NASDAQ	Biotechnology	$647.59M	$14.87	-7.52%	-$73.87M	-7.95x	0.40
BLI	BERKELEY LIGHTS INC	NASDAQ	Biotechnology	$295.05M	$4.35	-10.68%	-$67.96M	-3.75x	0.38
VCYT	VERACYTE INC	NASDAQ	Biotechnology	$1.21B	$16.94	-5.57%	-$24.83M	-25.28x	0.08
XENE	XENON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.41B	$26.49	-6.79%	-$82.03M	-15.58x	0.03
LEXX	LEXARIA BIOSCIENCE CORP	NASDAQ	Biotechnology	$11.19M	$1.88	-6.93%	-$7.17M	-1.40x	0.02
SYBX	SYNLOGIC INC	NASDAQ	Biotechnology	$78.68M	$1.12	-7.44%	-$56.46M	-1.15x	0.20
IMGN	IMMUNOGEN INC	NASDAQ	Biotechnology	$780.70M	$3.54	-0.84%	-$127.44M	-5.90x	0.57
FNCH	FINCH THERAPEUTICS GROUP INC	NASDAQ	Biotechnology	$96.54M	$2.03	-10.96%	-$65.49M	-1.39x	0.14
PTGX	PROTAGONIST THERAPEUTICS INC	NASDAQ	Biotechnology	$374.65M	$7.70	-1.66%	-$119.50M	-2.97x	0.15
VRNA	VERONA PHARMA PLC	NASDAQ	Biotechnology	$252.34M	$4.18	0.97%	-$58.15M	-4.02x	0.34
LMNL	LIMINAL BIOSCIENCES INC	NASDAQ	Biotechnology	$15.83M	$0.51	-1.92%	$24.83M	0.86x	1.65
ABCL	ABCELLERA BIOLOGICS INC	NASDAQ	Biotechnology	$2.07B	$7.26	-5.35%	$311.96M	10.08x	0.32
JANX	JANUX THERAPEUTICS INC	NASDAQ	Biotechnology	$455.84M	$10.95	-1.44%	-$43.61M	-7.35x	0.04
SGEN	SEAGEN INC	NASDAQ	Biotechnology	$24.57B	$133.47	-4.21%	-$609.49M	-35.40x	0.21
VCNX	VACCINEX INC	NASDAQ	Biotechnology	$49.49M	$1.16	2.65%	-$19.77M	-1.78x	0.12
OCUL	OCULAR THERAPEUTIX INC	NASDAQ	Biotechnology	$237.95M	$3.10	-5.49%	-$13.21M	-10.69x	1.35
DVAX	DYNAVAX TECHNOLOGIES CORP	NASDAQ	Biotechnology	$1.42B	$11.28	-1.14%	$124.61M	12.82x	2.51
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$8.71B	$34.11	-4.43%	$353.50M	18.54x	3.63
RYTM	RHYTHM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$169.32M	$3.36	-1.47%	-$186.83M	-1.02x	0.21
ITOS	ITEOS THERAPEUTICS INC	NASDAQ	Biotechnology	$588.91M	$16.57	-5.37%	$390.19M	1.96x	0.36
BLCM	BELLICUM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$12.23M	$1.42	5.19%	-$5.94M	-71.00x	0.46
HCM	HUTCHMED (CHINA) LTD	NASDAQ	Biotechnology	$1.49B	$8.59	-10.61%	-$182.14M	-6.87x	0.34
RPRX	ROYALTY PHARMA PLC	NASDAQ	Biotechnology	$24.13B	$39.74	-0.77%	$778.16M	27.60x	0.71
DYAI	DYADIC INTERNATIONAL INC	NASDAQ	Biotechnology	$66.42M	$2.35	7.31%	-$12.27M	-5.34x	0.13
ITCI	INTRA-CELLULAR THERAPIES INC	NASDAQ	Biotechnology	$5.37B	$56.96	-2.48%	-$302.92M	-15.65x	0.10
FSTX	F-STAR THERAPEUTICS INC	NASDAQ	Biotechnology	$55.24M	$2.57	-6.20%	-$32.71M	-1.67x	0.30
SRPT	SAREPTA THERAPEUTICS INC	NASDAQ	Biotechnology	$6.02B	$68.84	-3.87%	-$303.14M	-16.20x	2.57
ADMA	ADMA BIOLOGICS INC	NASDAQ	Biotechnology	$361.29M	$1.84	-11.11%	-$59.17M	-3.83x	1.43
JNCE	JOUNCE THERAPEUTICS INC	NASDAQ	Biotechnology	$224.78M	$4.35	-6.45%	-$99.06M	-2.20x	0.14
ROIV	ROIVANT SCIENCES LTD	NASDAQ	Biotechnology	$2.71B	$3.91	7.12%	-$555.63M	195.50x	0.28
NHWK	NIGHTHAWK BIOSCIENCES INC	NYSEMKT	Biotechnology	$61.56M	$2.40	3.90%	-$35.01M	-1.69x	0.09

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN)

COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN) is the top biotech stock with a Zen Score of 79, which is 49 points higher than the biotech industry average of 30. It passed 25 out of 33 due diligence checks and has strong fundamentals. COLLPLANT BIOTECHNOLOGIES has seen its stock lose -40.33% over the past year, overperforming other biotech stocks by 4 percentage points.

COLLPLANT BIOTECHNOLOGIES has an average 1 year price target of $21.50, an upside of 138.62% from COLLPLANT BIOTECHNOLOGIES's current stock price of $9.01.

COLLPLANT BIOTECHNOLOGIES stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering COLLPLANT BIOTECHNOLOGIES, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. CATALYST PHARMACEUTICALS (NASDAQ:CPRX)

CATALYST PHARMACEUTICALS (NASDAQ:CPRX) is the second best biotech stock with a Zen Score of 74, which is 44 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. CATALYST PHARMACEUTICALS has seen its stock return 20.74% over the past year, overperforming other biotech stocks by 65 percentage points.

CATALYST PHARMACEUTICALS has an average 1 year price target of $11.60, an upside of 68.85% from CATALYST PHARMACEUTICALS's current stock price of $6.87.

CATALYST PHARMACEUTICALS stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering CATALYST PHARMACEUTICALS, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. EXELIXIS (NASDAQ:EXEL)

EXELIXIS (NASDAQ:EXEL) is the third best biotech stock with a Zen Score of 72, which is 42 points higher than the biotech industry average of 30. It passed 23 out of 33 due diligence checks and has strong fundamentals. EXELIXIS has seen its stock lose -25.25% over the past year, overperforming other biotech stocks by 19 percentage points.

EXELIXIS has an average 1 year price target of $32.67, an upside of 84.56% from EXELIXIS's current stock price of $17.70.

EXELIXIS stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering EXELIXIS, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. SIGA TECHNOLOGIES (NASDAQ:SIGA)

SIGA TECHNOLOGIES (NASDAQ:SIGA) has an annual dividend yield of 4.92%, which is 3 percentage points higher than the biotech industry average of 1.71%.

SIGA TECHNOLOGIES's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. ROYALTY PHARMA (NASDAQ:RPRX)

ROYALTY PHARMA (NASDAQ:RPRX) has an annual dividend yield of 1.81%, which is the same as the biotech industry average of 1.71%.

ROYALTY PHARMA's dividend payout ratio of 48.6% indicates that its dividend yield is sustainable for the long-term.

3. NOVO NORDISK A S (NYSE:NVO)

NOVO NORDISK A S (NYSE:NVO) has an annual dividend yield of 1.48%, which is the same as the biotech industry average of 1.71%. NOVO NORDISK A S's dividend payout is not stable, having dropped more than 10% seven times in the last 10 years. NOVO NORDISK A S's dividend has shown consistent growth over the last 10 years.

NOVO NORDISK A S's dividend payout ratio of 52.5% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -2.9% in the last day, and down -4.26% over the last week. GENOCEA BIOSCIENCES was the among the top losers in the biotechnology industry, dropping -72.65% yesterday.

Genocea Biosciences shares are trading lower after the company announced it's winding down operations and delisting from NASDAQ.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. SESEN BIO (NASDAQ:SESN)

SESEN BIO (NASDAQ:SESN) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. SESEN BIO has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

SESEN BIO's stock has dropped -82.28% in the past year. It has underperformed other stocks in the biotech industry by -38 percentage points.

2. UNIVERSE PHARMACEUTICALS (NASDAQ:UPC)

UNIVERSE PHARMACEUTICALS (NASDAQ:UPC) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. UNIVERSE PHARMACEUTICALS has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

UNIVERSE PHARMACEUTICALS's stock has dropped -67.6% in the past year. It has underperformed other stocks in the biotech industry by -23 percentage points.

3. COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN)

COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. COLLPLANT BIOTECHNOLOGIES has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

COLLPLANT BIOTECHNOLOGIES's stock has dropped -40.33% in the past year. It has overperformed other stocks in the biotech industry by 4 percentage points.

Are biotech stocks a good buy now?

51.7% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 154.79% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 0.22x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.